Profitelligence Profitelligence · Filing Ledger Open DHR research →

Form 8-K · Current Report · Filed 2026-08-03

Danaher Appoints Julie Sawyer Montgomery as New CEO

Danaher Corporation announced the appointment of Julie Sawyer Montgomery as its new President and Chief Executive Officer, effective October 1, 2026.

Filer
Danaher Corporation DHR · NYSE
Filed
Accession
0001193125-26-330652
CIK
0000313616
Signal
High impactHealthcare

Details

Montgomery, who has been with the company since 2017, will succeed Rainer M. Blair, who will retire and serve as a Senior Advisor until December 31, 2026, and then as a consultant until March 31, 2027. The transition is part of a broader leadership change that includes special equity incentive awards for key leadership members and founders. The company expects no change to its previously communicated third quarter and full-year 2026 guidance.

Items reported

Item events

Reported Item

New CEO Appointed CEO Resignation

Market reaction

Close before filing

$194.98

Since filing

+0.0%

Latest close

$194.98

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from DHR reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, DHR insiders reported 7 Form 4 transactions — net selling of $12K.

Full DHR insider history →

About Danaher Corporation

Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another DHR filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts